Your browser doesn't support javascript.
loading
Biochemical Properties and Immunogenic Epitopes of Echinococcus granulosus Glutathione S-Transferase as a Vaccine Target: In-Silico Study.
Khazaei, Sasan; Dalimi, Abdolhossein; Pirestani, Majid; Ghafarifar, Fatemeh.
Afiliação
  • Khazaei S; Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Dalimi A; Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Pirestani M; Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Ghafarifar F; Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Iran J Parasitol ; 19(1): 61-74, 2024.
Article em En | MEDLINE | ID: mdl-38654954
ABSTRACT

Background:

The current in silico study was done to determine the primary biochemical features and immunogenic epitopes of Echinococcus granulosus glutathione S-transferase protein as a potential vaccine candidate.

Methods:

Several web tools were employed to predict physico-chemical properties, antigenicity, allergenicity, solubility, post-translational modification (PTM) sites, subcellular localization, signal peptide, transmembrane domain, secondary and tertiary structure followed by refinement and validations. In addition, B-cell epitopes were predicted and were screened using various web servers, while MHC-binding and CTL epitopes were predicted using IEDB and NetCTL servers, respectively.

Results:

The protein had 219 residues with a molecular weight of 25.55 kDa and alkaline isoelectric pH (7.5). This protein was stable, thermo-tolerant (aliphatic index 78.04) and hydrophilic (GRAVY -0.440). The predicted antigenicity scores were low and the protein was nonallergenic in nature. There were no transmembrane domain and signal peptide in the sequence. Moreover, several B-cell, MHC-binding and CTL epitopes were found in the EgGST protein, which could be further used in multi-epitope vaccines.

Conclusion:

Further studies are needed on the development of vaccines in vivo using EgGST alone or in combination with other antigens in the future.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article